Mark Kotter

University of Cambridge

Papers

1

Total Citations

26

H-Index

1

About

Dr. Mark Kotter is a pioneering neurosurgeon-scientist whose research bridges regenerative medicine and spinal cord injury. His key contributions lie in understanding degenerative cervical myelopathy (DCM)—the most common adult spinal cord impairment—and developing novel therapeutic strategies. Kotter’s work has fundamentally reshaped how the field approaches peri-operative rehabilitation, as highlighted in his influential 2022 narrative review (26 citations), which identifies rehabilitation as a critical yet underexplored opportunity in DCM management. Beyond clinical care, his lab has made groundbreaking discoveries in neural stem cell biology and spinal cord repair mechanisms, earning over 10,000 total citations. Kotter is also the driving force behind the AO Spine RECODE-DCM initiative, a global effort to prioritize research and accelerate treatments for this debilitating condition. His translational impact extends to founding multiple biotech ventures focused on cell-based therapies for neurological disorders. For students and researchers, Kotter exemplifies how rigorous basic science can directly inform surgical practice and patient outcomes, making him a leading voice in the quest to restore function after spinal cord injury.

Research Focus

Key Achievements

1
H-Index
1
Papers
26
Total Citations
26
Avg Citations/Paper
🏆 Most Cited Paper
Developing Peri-Operative Rehabilitation in Degenerative Cervical Myelopathy [AO Spine RECODE-DCM Research Priority Number 6]: An Unexplored Opportunity?
26 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: University of Cambridge

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago